Abstract. As functional changes in L-type high voltage-gated calcium channels (HVCCs) are recognized to be one of the major neurochemical modifications occurring in brains of animals with morphine physical dependence, this study attempts to examine whether regional difference in the expressions of HVCC subunits are produced in the brains under such pathological conditions. Scatchard analysis of [
Introduction
In brains derived from animals physically dependent on morphine, a variety of neurochemical alterations such as receptor functions with their conformational changes and protein levels or receptors on neuronal membrane, intracellular signal transduction systems including cAMP-generating systems, phosphorylation of functional protein molecules by several types of protein kinases, and transcription have been reported (1, 2) . Among such neurochemical events, the functional changes in high-voltage gated calcium channels (HVCCs) in the cerebral cortex, especially in L-type HVCCs (3 -6) , have been noted in morphine physical dependence as well as in ethanol physical dependence (7 -10) , and these changes of L-type HVCCs are supposed to be in part involved in the development of morphine physical dependence.
The molecular structure of HVCCs has been well investigated during the last two decades. HVCCs are heterometric complexes, and show an electrophysiological and pharmacological diversity (11 -16) . The pore-forming α1 subunits are membrane-anchoring proteins and are associated with several accessory subunits regulating α1 subunit functions such as cytoplasmic β subunits, transmembranous γ subunits, and α2/ δ subunits of which a large part is located in extracellular space. Ca 2+ channels of P / Q-and N-type HVCCs were formed by Ca v 2.1 (α1A) and Ca v 2.2 (α1B), respectively. In the case of L-type HVCCs, the subunits to form Ca 2+ channels are divided into four isoforms, Ca v 1.1 (α1S), Ca v 1.2 (α1C), Ca v 1.3 (α1D), and Ca v 1.4 (α1F); and all of these subunits have dihydropyridine binding sites (12, 13) . α1C and α1D subunits are localized in neurons, and α1S and α1F subunits are dominantly present in skeletal muscles and retina, respectively (12, 13), although we reported the presence of the α1F subunit in mouse cerebral cortical neurons (17) . Among these subunits of L-type HVCCs, α1C and α1D subunits are up-regulated in the cerebral cortex of animals physically dependent on ethanol and nicotine (10, 18) . On the other hand, there are little available data on changes in the expression of L-type HVCC subunits in animal brains with morphine physical dependence, despite several reports demonstrating up-regulated function of L-type HVCCs by using the radiolabeled dihydropyridine binding assay (7) . In this study we therefore examined which subunits are changed in animal brains after the development of morphine physical dependence, especially in the cerebral cortex, mesolimbic region including prefrontal cortex and nucleus accumbens, and cerebellum. The former two brain regions are supposed to be the critical for the development of morphine dependence (19, 20) . 
Materials and Methods

Materials
Animals
Male ddY strain mice weighing 30 g were obtained from Japan SLC (Hamamatsu) and used after feeding with solid laboratory chow (Oriental Yeast Co., Ltd., Chiba) and tap water ad libitum for 1 week.
The experiments using mice were approved by the Animal Research Committee of Kawasaki Medical School and conducted according to the "Guideline for the Care and Use of Laboratory Animals" of Kawasaki Medical School based on the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23), revised 1996. All efforts were made to minimize animal suffering, to reduce the number of animals used, and to utilize alternatives for the in vivo techniques, if available.
Chronic morphine treatment
Mice with morphine physical dependency were prepared according to the previous methods with a minor modification (21, 22) . Mice were administered morphine twice a day (09:00 and 21:00 around the clock) with daily increasing doses over a period for 5 days. The doses of morphine were subcutaneously injected on days 1 (8 and 15 mg / kg), 2 (20 and 25 mg / kg), 3 (30 and 35 mg / kg), 4 (40 and 45 mg / kg), and 5 (45 mg / kg at 09:00 only). All mice began to exhibit withdrawal signs such as jumping, ptosis, tremor, and diarrhea 3 h after the final injection and the severest signs were observed 6 h after the last dose of morphine. As these data indicate that the protocol of morphine administration used here produces morphine physical dependence after less than 3 h of the last dose of morphine, several brain regions such as the cerebral cortex, mesolimbic system [including forebrain, nucleus accumbens (NAcc), and ventral tegmental area (VTA)], and cerebellum are dissected from the mouse 1 h after the last administration of morphine.
In order to examine the acute effect of morphine on HVCC functions, a single dose (45 mg/ kg at 09:00) of morphine was administered to the mice and then their brains were dissected at 1 or 24 h after this subcutaneous injection.
The animals subcutaneously injected with saline alone instead of morphine were used as the control. H]PN200-110, a radiolabeled dihydropyridine derivative, were prepared as described below. Mice were decapitated, and the cerebral cortex, mesolimbic region, and cerebellum were dissected. The brain preparations were homogenized with a Polytron homogenizer with ice-cold phosphate buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , and 1.8 mM KH 2 PO 4 , pH 7.4), and centrifuged (48,000 × g, 4°C, 20 min). Pellets obtained were resuspended in the same buffer and centrifuged again. After washing the pellet three times by the washing procedures described above, the final pellet was stored at −80°C until use. Before the binding experiment, the frozen pellet was thawed, suspended with ice-cold PBS, and washed three times under the same conditions as described above.
[ H]PN200-110 varying from 0.0625 to 2.5 nM. Non-specific binding was assessed in the presence of 10 µM unlabeled (±)PN200-110. Bound ligand was assessed by filtration through Whatman GF / B filters followed by three washes with 6 ml of the binding buffer.
Protein extraction from various brain regions
The chest and abdominal wall of the mouse deeply anesthetized with sodium thiopental were opened by a U-shaped incision and the abdominal vena cava inferior was cut off. Immediately after these operations the brain was perfused with 0.15 M NaCl through a cannula inserted into the right ventricle with the flow rate of 20 ml / min for 1 min and further perfused with 6% TCA in 0.15 M NaCl for 3 min. The cerebral cortex, mesolimbic region, and cerebellum were dissected, sonicated, and centrifuged (10,000 × g, 5 min, 4°C). Each pellet was washed with ice-cold Tris-HCl buffer (pH 7.4), mixed with the sample buffer [4% sodium lauryl sulfate (SDS), 12% β-mercaptoethanol, and 20% glycerol in 100 mM Tris-HCl (pH 6.8)], sonicated (1 min), boiled (3 min), and finally centrifuged (10,000 × g, 60 min, 4°C) (10). The resultant supernatants were stored at −80°C until use for protein electrophoresis.
Protein electrophoresis and immunoblots for HVCCs
After SDS-PAGE gel electrophoresis on a 7.5% gel (10 × 10 cm in size, 0.5-mm thickness) was performed (20 mA for 90 min), the separated proteins in the gel were transferred onto a nitrocellulose filter using a semidry-type transblotter (160 mA for 120 min) (17) . The nitrocellulose filters were washed with PBS and blocked with Tris-buffered saline [TBS: 20 mM Tris-HCl (pH 7.4) containing 0.15 M NaCl] containing 5% skim milk at room temperature for 60 min. For immunoblotting, the nitrocellulose filters were incubated overnight at 4°C with the antibodies against β4 subunits; each α1 subunit of L-, N-, and P / Q-types of HVCCs; and α2/ δ1 subunit (diluted 1 / 200-1 / 1,000 in PBS containing 0.1% normal serum). After washing three times with TBS containing 0.05% Tween 20, the antigenic protein bands were stained using anti rabbit-IgG antibody conjugated with alkaline phosphatase (diluted 1 / 2,500). For protein staining, the blots were stained using Coomassie brilliant blue staining kit (Bio-Rad, Lab. Inc., Hercules, CA, USA).
The α1A, α1B, α1C, α1D, α2 / δ1, and β4 subunits were each recognized as a single band with molecular weigh of 190, 240, 210, 260, 150, and 55 kDa, respectively, by immunostaining with their respective antibodies after electrophoresis (data not shown).
The relative intensity of immunoreactive bands for each subunit for HVCCs was calculated using ImageMaster 1D Elite software (Amersham Pharmacia Biotech, Buckinghamshire, England), and the data were estimated as percent of each control (without morphine treatment).
Measurement of protein content
The protein content in the brains was determined by the method of Lowry et al. (26) with bovine serum albumin as standard.
Statistical analysis
The data were each expressed as the mean ± S.E.M. The statistical significance was assessed by the methods described in each figure legend following the application of the one-way ANOVA.
Results
Changes of [
3 H]PN200-110 binding in various brain regions from mice with morphine physical dependence Figure 1 shows the binding parameters of [ 3 H]PN200-110 binding to the particulate fractions of various brain regions from mice physically dependent on morphine. In the cerebral cortex, the Bmax value in morphine-treated animals significantly increased compared to that in nontreated animals, although there was no significant difference in binding affinity between both types of animals (Fig. 1A) . Similar difference in the binding parameters was found in the mesolimbic region (Fig. 1B) , whereas there was no difference in the binding parameters in the cerebellum from morphine-treated and non-treated animals (Fig. 1C) .
Changes of HVCC subunit levels in various brain regions from mice with morphine physical dependence
As shown in Fig. 2A , chronic treatment with morphine up-regulated not only the α1C and α1D subunits of L-type HVCCs but the α2 / δ1 subunit in the cerebral cortex, although the β4 subunit level was found to be reduced. In the mesolimbic region of mice physically dependent on morphine, increased expressions of both α1C and α1D subunits were noted with no changes in α2/ δ1 and β4 subunit levels (Fig. 2B) . In contrast to the changes of α1 subunits in the cerebral cortex and the mesolimbic region, the expressions of α1C and α1D subunits in the cerebellum did not change (Fig. 2C) . However, the treatment reduced α1B of N-type HVCCs and α2/ δ1 subunits in the cerebellum (Fig. 2C) .
Changes of HVCC subunit levels in various brain regions from mice after a single administration of morphine
A single dose (45 mg/ kg) of morphine did not affect the expression of any of the subunits of HVCCs examined in all brain regions even at 1 or 24 h after administration (Fig. 3: A, B , and C).
Discussion
Functional modifications of HVCCs, especially Ltype HVCCs, in the central nervous system are well recognized as one of the neurochemical events occurring in the development of physical dependence by drugs of abuse such as ethanol, morphine, and benzodiazepines, although the pathophysiological role of such functional changes in L-type HVCCs in the development of physical dependence and the emergence of physical and psychological symptoms remains elusive (7) .
This study demonstrates the differences in the binding of [
3 H]PN200-110, a radiolabeled dihydropyridine derivative, among brain regions including the cerebral cortex, mesolimbic region, and cerebellum from mice showing morphine physical dependence. That is, the increases in [
3 H]PN200-110 binding found in the cerebral cortex and the mesolimbic region are due to the increased Bmax values of the binding. Similar increases in the bindings of radiolabeled dihydropyridines in the cerebral cortex (3 -6), hippocampus (3, 5, 27) , and mesolimbic system (4) from the animals suffering from morphine physical dependence were reported and the increased binding was also confirmed to be due to their increased Bmax values. On the other hand, chronic morphine treatment had no effects on the radiolabeled dihydropyridine bindings in the striatum (3, 4) and cerebellum (3). The results presented in this study also show no effects on the [
3 H]PN200-110 binding in the cerebellum after chronic morphine administration.
The binding sites of dihydropyridines are well recognized to be localized in repeats IV, III, and I of the α1 subunits (12) . Therefore, the increases in Bmax values of [
3 H]PN200-110 binding at least suggest that there are increased levels of α1 subunits in the L-type HVCCs. Indeed, the immunoblot analysis of L-type HVCC subunits reveals the increases in α1C and α1D subunits in the cerebral cortex and mesolimbic system, which is considered to be in good agreement with the increased [
3 H]PN200-110 binding sites in these brain regions. In the cerebellum showing no changes in [ 3 H]PN200-110 binding, the expressions of α1C and α1D subunits have no alterations, which is considered to well correspond to the data of radiolabeled dihydropyridine binding presented here and the data reported by Ramkumar and El-Fakahany (3).
The previous investigations report that chronic treatments with ethanol and nicotine induce not only physical dependence in animals but also up-regulation of L-type HVCC subunits such as α1C, α1D, and α2 / δ1 in the cerebral cortex (10, 18) . In addition, the up-regulation of L-type HVCC subunits similar to that observed in the cerebral cortex from animals with physical dependence on ethanol and nicotine occurs in neuronal cells continuously exposed to ethanol and nicotine as well as morphine (17, 25, 28, 29) . The previously reported observations and the present data obtained by the radiolabeled dihydropyridine binding assay and immunoblot analysis for L-type HVCC subunits indicate that the up- regulation of α1C and α1D of L-type HVCCs and the α2/ δ1 subunit play important roles in the development of physical dependence on morphine as well as ethanol and nicotine.
It may be reasonable to suppose that the increased level of α2 / δ subunits positively modify the function of L-type HVCCs because α2/ δ subunits work to enhance the opening probability of channels of which ionophores are formed by α1 subunits (30 -32) . The decreased expression of the α2 / δ1 subunit in the cerebellum after chronic administration of morphine may have a role to further suppress the decreased function of N-type HVCCs induced by the decreased level of α1B subunit in the cerebellum. However, the exact functional significance of such decreased expression of the α2 / δ1 subunit in the cerebellum is not clear at present. On the other hand, the β4 subunit was decreased in the cerebral cortex, but its levels were not altered in the mesolimbic region and cerebellum. The previous investigations reveal that β subunits facilitate Ca 2+ currents via modification of inactivation kinetics of channel interaction with second messenger regulation (33 -35) . Similarly, the decreases of β4 subunit in the cerebral cortex after chronic treatment with ethanol (10) and in primary cultures of cerebral cortical neurons continuously exposed to ethanol and morphine (25, 29) were reported. However, the pathophysiological roles of the decrease of β4 subunit levels observed in the cerebral cortex from mice with morphine physical dependence remain to be elucidated at present.
Although the present study and a previous investigation (3) demonstrate no alterations of α1 subunit proteins of L-type HVCCs in the cerebellum from animals with morphine physical dependence, this study showed that the α1B subunit of N-type HVCCs decreased in the cerebellum. A previous report demonstrated that N-type HVCCs are directly suppressed by µ-opioid receptor activation in a human neuroblastoma cell line (SH-SY5Y) (36) . In this study, the cerebellum was dissected from the mouse 1 h after the last dose of morphine, possibly resulting in residual morphine in the brain tissues and this residual morphine in turn would cause direct inhibition on N-type HVCCs. However, this possibility is not likely because the changes of N-type HVCCs in the cerebellum are due to the decreased level of α1B subunit protein, but not the decrease in N-type HVCCs functions. In addition, the possibility described above can not explain why there are no alterations of α1B subunit protein expression in the cerebral cortex and mesolimbic region. Therefore, it is difficult to provide a conclusive explanation for the decreased expressions of N-type HVCCs in the cerebellum with the data available at present, and the mechanisms and pathophysiological significance of this event remain as problems for future elucidation.
In the present study, we examined whether a single dose (45 mg / kg) of morphine affects the expression of HVCC subunits because the preparation of HVCC subunit proteins is carried out 1 h after the last dose of morphine and the possibility that this finally administrated morphine may change the expression is considered to be a potential problem. However, the single dose (45 mg / kg) of morphine did not produce any changes in the expression of any of the HVCC subunits at either 1 or 24 h after the administration. These data clearly indicate that chronic administration of morphine, but not acute administration, changes the expression of α1C and α1D subunits of L-type HVCCs and the α2 / δ1 subunit.
In summary, we examined changes in the expression of HVCC subunits in the brains of mice with morphine physical dependence. [
3 H]PN200-110 binding showed increased Bmax values in the cerebral cortex and mesolimbic region including the nucleus accumbence, but not in the cerebellum. In the former two brain regions, α1C and α1D subunits of L-type HVCCs and the α2 / δ1 subunit increased, although decreases of α1B and α2 / δ1 subunits were observed in the cerebellum. These results indicate that the increased L-type HVCC subunits in the cerebral cortex and mesolimbic region participate in the development of morphine physical dependence.
